政府:與復星醫藥(02196.HK)採購協議無賦權或容許收集疫苗接種者個人資料
政府留意到有外國媒體於前日(12日)報道稱香港特別行政區政府與復星實業(香港)有限公司(復星)所簽訂的採購協議中,有條款賦權復星蒐集香港的疫苗接種者的個人資料。政府發言人今日(7月13日)澄清有關報道嚴重失實,並對相關誤導性報道表示極度遺憾。
政府發言人表示,特區政府與復星所簽訂的採購協議中,並無任何條款涉及賦權或容許復星或任何第三方蒐集、取覽,或以任何方式獲取或使用疫苗接種者的個人資料。
特區政府一向高度重視個人資料私隱,尤其是對醫療紀錄和相關資料的保護。本港的新冠疫苗接種計劃就個人資料的蒐集和使用有清晰及嚴格的指引和程序,並符合《個人資料(私隱)條例》的相關規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.